Showing results (1-10 of 430) with videos related to
Sort By:
Pageof 43
Expert Review of Neurotherapeutics|May 1, 2009
Cholesterol-modifying strategies for Alzheimer's diseaseAlina Solomon, Miia KivipeltoJournal of Alzheimer'S Disease : JAD|July 4, 2012
Prevention of Alzheimer's disease: moving backward through the lifespanAlina Solomon, Miia Kivipelto, Hilkka SoininenBiochemical Society Transactions|July 28, 2010
Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairmentValerio Leoni, Alina Solomon, Miia KivipeltoAlzheimer'S Research & Therapy|February 21, 2012
Dementia prevention: current epidemiological evidence and future perspectiveFrancesca Mangialasche, Miia Kivipelto, Alina Solomon, et al.Journal of Alzheimer'S Disease : JAD|June 29, 2011
Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish settingYanlei Zhang, Miia Kivipelto, Alina Solomon, et al.Journal of Alzheimer'S Disease : JAD|July 31, 2012
Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studiesAnna-Maija Tolppanen, Alina Solomon, Hilkka Soininen, et al.Neuroscience Letters|September 8, 2007
Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disordersMarjan Shafaati, Alina Solomon, Miia Kivipelto, et al.The Lancet. Neurology|July 9, 2010
Alzheimer's disease: clinical trials and drug developmentFrancesca Mangialasche, Alina Solomon, Bengt Winblad, et al.Journal of Alzheimer'S Disease : JAD|December 17, 2016
Estradiol and Cognition in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Cohort StudyBushra Imtiaz, Anna Maija Tolppanen, Alina Solomon, et al.Dementia and Geriatric Cognitive Disorders|August 4, 2009
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades laterAlina Solomon, Miia Kivipelto, Benjamin Wolozin, et al.Pageof 43